Seeking Alpha


Send Message
View as an RSS Feed
View D.Rapp's Comments BY TICKER:
Latest  |  Highest rated
  • El Pollo Loco - What's Left After Very Strong Opening Day Returns? [View article]
    LOL. Love the Gus Fring comment.
    Jul 30 03:08 PM | Likes Like |Link to Comment
  • Quantifying iPhone 6's Potential Cannibalization Of iPad, It Is Not Pretty [View article]
    Apple's joint venture with IBM to develop more apps for the ipad in order to make it more functional (vis a vis a laptop or desktop) will rejuvenate ipad sales.
    Jul 24 12:15 PM | 1 Like Like |Link to Comment
  • Why This Physician Is Bullish On Celgene [View article]
    I have been a CELG shareholder for about 6 years now. This was probably the most informative and comprehensive article on the company that I've had the pleasure to read. Well done.
    Jun 28 03:29 PM | 1 Like Like |Link to Comment
  • Gilead Sciences: Killing The Competition With Sovaldi; But Does This Make Gilead A One-Trick Pony? [View article]
    Are you that clueless? Go ahead and short this stock. Make my day.
    Jun 9 08:03 PM | 5 Likes Like |Link to Comment
  • Gilead Science - Sovaldi's Pricing In A New Perspective [View article]
    Fully valued with a current PEG at approximately 0.33? You don't appear to know much about the fundamentals of this stock.
    May 6 02:56 PM | 1 Like Like |Link to Comment
  • Gilead's Sovaldi Is The Solution, Not The Problem [View article]
    Very informative and insightful article. Keep up the good work.
    Apr 30 12:07 AM | Likes Like |Link to Comment
  • The Market Is Selling Celgene; I'm A Buyer [View article]
    While, I don't expect Mylan to prevail in their suit for access to Revlimid, can you comment about how long Celgene can maintain exclusive rights to Revlimid and what's in the pipeline to replace such a substantial portion of revenues (66%) when that day comes.
    Apr 5 04:45 PM | Likes Like |Link to Comment
  • Amgen's Evolocumab slashes "bad" cholesterol by up to 66% in trial [View news story]
    What idiotic comments (above) to what is clearly good news for shareholders and those with high cholesterol.
    Mar 30 12:50 PM | 1 Like Like |Link to Comment
  • Gilead Is An Avoid [View article]
    B.S. Look at ILMN. The stock tanked all the way down to about $30 per share a couple of years ago. It's now trading at $155 and actually traded as high as $180's. Netflix when it fell to about $60 is now trading in the $400's. There are hundreds of these type of examples. You are too short sighted.
    Mar 23 11:25 AM | Likes Like |Link to Comment
  • The 7-Year Cycle That Will Crush Uninformed Investors, Again [View article]
    OK , so you're saying the market will hit a new high this year? Wahoo!!
    Feb 3 06:59 PM | 3 Likes Like |Link to Comment
  • What Now After A Miserable Monday? [View article]
    "Stocks have risen by nearly +50% over the last two years on virtually no revenue or earnings growth and almost exclusively on the adrenaline of extraordinarily aggressive monetary stimulus from the U.S. Federal Reserve."

    I don't know what stocks you're in, but as a general statement I think this is an inaccurate and irresponsible statement.
    Feb 3 06:32 PM | 10 Likes Like |Link to Comment
  • What Now After A Miserable Monday? [View article]
    Are you serious? What kind of "Analyst" are you?
    Feb 3 06:26 PM | 23 Likes Like |Link to Comment
  • What Now After A Miserable Monday? [View article]
    Finally, thank you, a rational post. I saw Cramer freaking out tonight which by the way is a bullish indictor. Always do the opposite of what Cramer tells to do and you'll be fine.
    Feb 3 06:20 PM | 19 Likes Like |Link to Comment
  • Perspectives On Friday's Sell Off [View article]
    Who do you like in the Super Bowl?
    Jan 26 10:14 AM | 2 Likes Like |Link to Comment
  • Actavis: The Growth Of Biotech With The Valuation Of Large Pharma [View article]
    We'll written analysis. Actavis is one of my best performers.
    Jan 22 01:07 PM | Likes Like |Link to Comment